Insider · CIK 0001772130
Catherine Moukheibir
Files at IRWD (IRONWOOD PHARMACEUTICALS INC), MLTX (MoonLake Immunotherapeutics). First filing Jun 10, 2024, latest Jul 7, 2025.
In brief
Catherine Moukheibir files SEC Form 4 as director at IRWD (IRONWOOD PHARMACEUTICALS INC), and also at MLTX (MoonLake Immunotherapeutics). Since Jun 10, 2024, Catherine Moukheibir has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.7M, the latest filed on Jul 7, 2025.
A track record needs three past buys with six months of prices behind them; Catherine Moukheibir has 0, so none is measured yet.
The newest scored trade: sold $1.1M of MLTX on Jul 3, 2025, filed Jul 7, 2025, scored 45 (moderate).
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
MLTX: MoonLake Immunotherapeutics
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
IRWD: IRONWOOD PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | MLTXsell MoonLake Immunotherapeutics | $1.1M 23,500 shares | -100% | - | |
| 61Notable | IRONWOOD PHARMACEUTICALS INC | $518k 80,000 shares | -62% | +10% from low-58% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | 23,500 0.04% of outstanding | $1.1M | Jul 3, 2025 | none |
| Jun 7, 2024 | IRWD IRONWOOD PHARMACEUTICALS INC | 35,574 0.02% of outstanding | $235k | Jun 7, 2024 | $282k |
| Jun 6, 2024 | IRWD IRONWOOD PHARMACEUTICALS INC | 44,426 0.03% of outstanding | $282k | Jun 6, 2024 | none |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivative | +22,195 | $0.00 | $0 | 22,195 | Jun 18, 2026 |
| Jun 16, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | AGrant or award Class A Common Stock | +63,481 | $0.00 | $0 | 181,425 | Jun 17, 2026 |
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | MOption exercise Class A ordinary shares, par value $0.0001 per share | +23,500 | $0.00 | $0 | 23,500 | Jul 7, 2025 |
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | SOpen-market sale Class A ordinary shares, par value $0.0001 per share | -23,500 | $48.79 | $1.1M | 0 | Jul 7, 2025 |
| Jul 3, 2025 | MLTX MoonLake Immunotherapeutics | MOption exercise Option to Buyderivative | -23,500 | $0.00 | $0 | 21,500 | Jul 7, 2025 |
| Jun 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | AGrant or award Class A Common Stock | +45,000 | $0.00 | $0 | 117,944 | Jun 12, 2025 |
| Jun 5, 2025 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivative | +6,682 | $0.00 | $0 | 6,682 | Jun 9, 2025 |
| Jun 18, 2024 | IRWD IRONWOOD PHARMACEUTICALS INC | AGrant or award Class A Common Stock | +24,311 | $0.00 | $0 | 72,944 | Jun 21, 2024 |
| Jun 6, 2024 | IRWD IRONWOOD PHARMACEUTICALS INC | SOpen-market sale Class A Common Stock | -44,426 | $6.36 | $283k | 84,207 | Jun 10, 2024 |
| Jun 7, 2024 | IRWD IRONWOOD PHARMACEUTICALS INC | SOpen-market sale Class A Common Stock | -35,574 | $6.61 | $235k | 48,633 | Jun 10, 2024 |
| Jun 6, 2024 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivative | +7,688 | $0.00 | $0 | 7,688 | Jun 7, 2024 |
| Dec 15, 2023 | IRWD IRONWOOD PHARMACEUTICALS INC | AGrant or award Class A Common Stock | +1,572 | $0.00 | $0 | 128,633 | Dec 19, 2023 |
Questions about Catherine Moukheibir
Answered from the filings on this page, as of the latest one.
Is Catherine Moukheibir buying or selling?
Not in the last 12 months. Catherine Moukheibir's latest open-market trade on SEC Form 4 was sold $1.1M of MLTX on Jul 3, 2025.
How did Catherine Moukheibir's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Catherine Moukheibir has 0.
Where does Catherine Moukheibir file Form 4?
Catherine Moukheibir has filed Form 4 at IRWD (IRONWOOD PHARMACEUTICALS INC); MLTX (MoonLake Immunotherapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.